KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Profit After Tax (2020 - 2025)

Ginkgo Bioworks Holdings' Profit After Tax history spans 6 years, with the latest figure at -$80.8 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 24.91% year-over-year to -$80.8 million; the TTM value through Dec 2025 reached -$312.8 million, up 42.83%, while the annual FY2025 figure was -$312.8 million, 42.83% up from the prior year.
  • Profit After Tax reached -$80.8 million in Q4 2025 per DNA's latest filing, roughly flat from -$80.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$54.5 million in Q2 2021 to a low of -$1.6 billion in Q4 2021.
  • Average Profit After Tax over 5 years is -$284.5 million, with a median of -$169.6 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: crashed 3298.1% in 2021, then soared 88.93% in 2022.
  • A 5-year view of Profit After Tax shows it stood at -$1.6 billion in 2021, then skyrocketed by 88.93% to -$176.9 million in 2022, then fell by 19.66% to -$211.7 million in 2023, then skyrocketed by 49.2% to -$107.5 million in 2024, then rose by 24.91% to -$80.8 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Profit After Tax are -$80.8 million (Q4 2025), -$80.8 million (Q3 2025), and -$60.3 million (Q2 2025).